BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9292254)

  • 1. Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG).
    Dreyer EB; Grosskreutz CL
    Clin Neurosci; 1997; 4(5):270-3. PubMed ID: 9292254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine.
    Vorwerk CK; Lipton SA; Zurakowski D; Hyman BT; Sabel BA; Dreyer EB
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1618-24. PubMed ID: 8675405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saving the nerve from glaucoma: memantine to caspaces.
    Naskar R; Vorwerk CK; Dreyer EB
    Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia.
    Lagrèze WA; Knörle R; Bach M; Feuerstein TJ
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1063-6. PubMed ID: 9579489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat.
    Nucci C; Tartaglione R; Rombolà L; Morrone LA; Fazzi E; Bagetta G
    Neurotoxicology; 2005 Oct; 26(5):935-41. PubMed ID: 16126273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
    Hare WA; WoldeMussie E; Lai RK; Ton H; Ruiz G; Chun T; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2625-39. PubMed ID: 15277486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel pharmacological targets to minimize excitotoxic retinal damage.
    Russo R; Rotiroti D; Tassorelli C; Nucci C; Bagetta G; Bucci MG; Corasaniti MT; Morrone LA
    Int Rev Neurobiol; 2009; 85():407-23. PubMed ID: 19607984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New horizons in neuroprotection.
    Naskar R; Dreyer EB
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S250-5; discussion S273-6. PubMed ID: 11377444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes in glaucomatous optic neuropathy.
    Hernandez MR; Miao H; Lukas T
    Prog Brain Res; 2008; 173():353-73. PubMed ID: 18929121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 attenuates normal tension glaucoma-like retinal degeneration in EAAC1-deficient mice.
    Namekata K; Harada C; Guo X; Kikushima K; Kimura A; Fuse N; Mitamura Y; Kohyama K; Matsumoto Y; Tanaka K; Harada T
    Neurosci Lett; 2009 Nov; 465(2):160-4. PubMed ID: 19766171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
    Thanos S; Naskar R
    Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection.
    Russo R; Cavaliere F; Rombolà L; Gliozzi M; Cerulli A; Nucci C; Fazzi E; Bagetta G; Corasaniti MT; Morrone LA
    Prog Brain Res; 2008; 173():575-82. PubMed ID: 18929135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder.
    Dkhissi O; Chanut E; Wasowicz M; Savoldelli M; Nguyen-Legros J; Minvielle F; Versaux-Botteri C
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):990-5. PubMed ID: 10102297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):353-5. PubMed ID: 18260297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma.
    Boland MV; Zhang L; Broman AT; Jampel HD; Quigley HA
    Ophthalmology; 2008 Feb; 115(2):239-245.e2. PubMed ID: 18082888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.
    Mittag TW; Danias J; Pohorenec G; Yuan HM; Burakgazi E; Chalmers-Redman R; Podos SM; Tatton WG
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3451-9. PubMed ID: 11006238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucoma as a neurodegenerative disease.
    Gupta N; Yücel YH
    Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreal glutamate concentration in monkeys with experimental glaucoma.
    Carter-Dawson L; Crawford ML; Harwerth RS; Smith EL; Feldman R; Shen FF; Mitchell CK; Whitetree A
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2633-7. PubMed ID: 12147596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey.
    Ramakrishnan R; Nirmalan PK; Krishnadas R; Thulasiraj RD; Tielsch JM; Katz J; Friedman DS; Robin AL
    Ophthalmology; 2003 Aug; 110(8):1484-90. PubMed ID: 12917161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing glaucomatous optic neuropathy in primary open angle and primary angle closure glaucoma eyes by scanning laser polarimetry-variable corneal compensation.
    Chen HY; Huang ML; Tsai YY; Hung PT; Lin EJ
    J Glaucoma; 2008 Mar; 17(2):105-10. PubMed ID: 18344755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.